| 199.511 -1.299 (-0.65%) | 04-19 15:59 | |||||||||||||
|
|
| Short term |   |
|||
| Mid term |  |
|||
| Targets | 6-month : | 257.89 | 1-year : | 274.48 |
| Resists | First : | 220.79 | Second : | 235 |
| Pivot price | 210.25  |
|||
| Supports | First : | 197.82 | Second : | 164.58 |
| MAs | MA(5) : | 201.05 |
MA(20) : | 213.87 |
| MA(100) : | 218.98 |
MA(250) : | 216.78 |
|
| MACD | MACD : | -7.2 |
Signal : | -5.7 |
| %K %D | K(14,3) : | 6.9 |
D(3) : | 4.2 |
| RSI | RSI(14): 26 |
|||
| 52-week | High : | 254 | Low : | 180.53 |
Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and NEUTRAL in mid-long term.[ STE ] has closed above bottom band by 19.6%. Bollinger Bands are 91.2% wider than normal. The large width of the bands suggest high volatility as compared to its normal range. The bands have been in this wide range for 11 days. This is a sign that the current trend might continue.
| If tomorrow: | Open lower | Open higher |
| High: | 202.14 - 203.48 | 203.48 - 204.69 |
| Low: | 194.48 - 196.2 | 196.2 - 197.76 |
| Close: | 197.6 - 200.29 | 200.29 - 202.73 |
STERIS plc provides infection prevention and other procedural products and services worldwide. It operates through four segments: Healthcare, Applied Sterilization Technologies, Life Sciences, and Dental. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; accessories for gastrointestinal (GI) procedures, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in the operating room, including surgical tables, lights, and connectivity solutions, as well as equipment management services. It also provides capital equipment installation, maintenance, upgradation, repair, and troubleshooting services; preventive maintenance programs and repair services; instrument and endoscope repair and maintenance services; and custom process improvement consulting and outsourced instrument sterile processing services. The Applied Sterilization Technologies segment provides contract sterilization and testing services for medical device and pharmaceutical manufacturers through a network of approximately 50 contract sterilization and laboratory facilities. The Life Sciences segment designs, manufactures and sells consumable products, such as formulated cleaning chemistries, barrier and sterility assurance products, steam and vaporized hydrogen peroxide sterilizers, and washer disinfectors. This segment also offers equipment installation, maintenance, upgradation, repair, and troubleshooting services; and preventive maintenance programs and repair services. The Dental segment provides hand and powered dental instruments, infection control products, personal protective equipment, and water quality products for dental suite. The company serves its products and services to hospitals, other healthcare providers, and pharmaceutical manufacturers. The company was founded in 1985 and is based in Dublin, Ireland.
Fri, 19 Apr 2024
NewEdge Wealth LLC Invests $244000 in STERIS plc (NYSE:STE) - Defense World
Fri, 19 Apr 2024
Does The Market Have A Low Tolerance For STERIS plc's (NYSE:STE) Mixed Fundamentals? - Simply Wall St
Fri, 19 Apr 2024
STERIS plc (NYSE:STE) Shares Sold by Sumitomo Mitsui Trust Holdings Inc. - Defense World
Fri, 19 Apr 2024
Mutual of America Capital Management LLC Sells 586 Shares of STERIS plc (NYSE:STE) - Defense World
Thu, 18 Apr 2024
STERIS (STE) Q1 Earnings Surpass Estimates, Margins Rise - Yahoo Movies UK
Thu, 18 Apr 2024
STERIS plc (NYSE:STE) Receives Consensus Rating of "Moderate Buy" from Brokerages - MarketBeat
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Outperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Outperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Outperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Outperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Outperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Outperform |
|
Exchange:
NYSE
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Medical - Devices
|
|
| Shares Out | 99 (M) |
| Shares Float | 98 (M) |
| Held by Insiders | 0.2 (%) |
| Held by Institutions | 97.9 (%) |
| Shares Short | 2,680 (K) |
| Shares Short P.Month | 2,460 (K) |
| EPS | 5.69 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 64.93 |
| Profit Margin | 10.4 % |
| Operating Margin | 15.8 % |
| Return on Assets (ttm) | 4.7 % |
| Return on Equity (ttm) | 9.1 % |
| Qtrly Rev. Growth | 14.8 % |
| Gross Profit (p.s.) | 0 |
| Sales Per Share | 54.75 |
| EBITDA (p.s.) | 14.37 |
| Qtrly Earnings Growth | 14.5 % |
| Operating Cash Flow | 934 (M) |
| Levered Free Cash Flow | 524 (M) |
| PE Ratio | 35.29 |
| PEG Ratio | 2.3 |
| Price to Book value | 3.09 |
| Price to Sales | 3.66 |
| Price to Cash Flow | 21.23 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|